Qkine

Specialist manufacturer of proteins for stem cell and regenerative medicine applications

Cambridge, UK—Website

£1.5MTotal raised

Qkine develops and manufactures high-purity recombinant growth factors, cytokines and other bioactive proteins for stem cell and regenerative medicine applications.

Founders

Marko Hyvönen

Co-Founder and CSO

Marko serves as a Research Group Head at the University of Cambridge and co-founded Qkine, where he acts as chief scientific officer. He also holds a visiting professorship at the Universidade de São Paulo.

Catherine Elton

CEO and Co-Founder

Catherine founded Qkine and held research roles at the Wellcome Trust Sanger Institute. She currently serves as chief business officer at Axol Bioscience and non-executive director at Atelerix.